In Brief: FDA ANDA notice
Executive Summary
FDA ANDA notice: ANDAs for acetaminophen and codeine phosphate tablets USP, 325 mg/45 mg, can be approved following FDA's determination that the drug was not withdrawn from sale for reasons of safety or effectiveness, according to a July 10 agency notice in the Federal Register...